Regal Rexnord
RRX
164.17
-2.19
-1.32%
Regal Rexnord
US · RRX
#1413 by market cap
Listed 1970
164.17
-2.19
-1.32%
Live - 5344 symbols - heartbeat 194s ago
· 2026-10-08 08:28
Pre-market
156.80
-4.49%
After-hours
162.70
-0.90%
Overnight
164.00
-0.10%
- Market cap
- 10.93B
- P/E (TTM)i
- 33.78
- P/Bi
- 1.58
- EPSi
- 4.20
- Div yieldi
- 0.85%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on RRX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.87, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.65% YoY
Margins
- Gross margin
- 37.37%
- Operating margin
- 11.55%
- Net margin
- 4.71%
Key ratios & quality
- Enterprise valuei
- 15.24B
- Altman Z-Scorei
- 1.87
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.65B | 3.24B | 2.91B | 3.81B | 5.22B | 6.25B | 6.03B | 5.93B |
| Gross profit | 964.60M | 860.70M | 806.60M | 1.11B | 1.67B | 2.07B | 2.19B | 2.22B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 365.20M | 316.40M | 293.70M | 396.90M | 691.30M | 522.10M | 638.50M | 685.30M |
| Pretax profit | 292.20M | 303.80M | 248.50M | 310.50M | 613.80M | -1.60M | 248.00M | 352.50M |
| Tax | 56.40M | 61.20M | 56.30M | 74.70M | 118.90M | 52.70M | 49.60M | 71.70M |
| Net profit | 235.80M | 242.60M | 192.20M | 235.80M | 494.90M | -54.30M | 198.40M | 280.80M |
| Basic EPS | 5 | 6 | 5 | 5 | 7 | -1 | 3 | 4 |
| Diluted EPS | 5.26 | 5.66 | 4.60 | 4.81 | 7.29 | -0.87 | 2.94 | 4.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.42B | 1.50B | 1.50B | 1.52B | 1.48B | 1.56B |
| Gross profit | 527.60M | 564.70M | 554.20M | 571.30M | 549.90M | 611.60M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 159.70M | 182.30M | 174.40M | 169.00M | 152.70M | 215.20M |
| Pretax profit | 73.00M | 101.20M | 91.90M | 86.50M | 76.50M | 143.70M |
| Tax | 15.50M | 21.60M | 11.90M | 22.70M | 12.20M | 26.90M |
| Net profit | 57.50M | 79.60M | 80.00M | 63.80M | 64.30M | 116.80M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.86 | 1.19 | 1.20 | 0.95 | 0.96 | 1.74 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.82B | 1.61B | 1.85B | 2.81B | 3.00B | 3.38B | 2.75B | 2.71B |
| Cash & ST investments | 248.60M | 331.40M | 611.30M | 672.80M | 688.50M | 574.00M | 393.50M | 521.70M |
| Inventory | 767.20M | 678.40M | 690.30M | 1.19B | 1.34B | 1.27B | 1.23B | 1.32B |
| Total assets | 4.62B | 4.43B | 4.59B | 10.37B | 10.27B | 15.43B | 14.03B | 13.92B |
| Total current liabilities | 683.50M | 560.50M | 822.00M | 1.10B | 1.00B | 1.33B | 1.22B | 1.26B |
| Short-term debt | 500.00K | 22.20M | 252.60M | 32.10M | 60.20M | 41.10M | 40.60M | 62.60M |
| Long-term debt | 1.31B | 1.14B | 840.40M | 1.91B | 1.99B | 6.38B | 5.45B | 4.76B |
| Total liabilities | 2,285,300,000.00 | 2,050,300,000.00 | 2,012,000,000.00 | 3,959,200,000.00 | 3,846,300,000.00 | 9,066,300,000.00 | 7,766,500,000.00 | 7,067,700,000.00 |
| Total equity | 2.34B | 2.38B | 2.58B | 6.41B | 6.42B | 6.37B | 6.27B | 6.85B |
| Retained earnings | 1.78B | 1.89B | 2.01B | 1.91B | 2.13B | 1.98B | 2.04B | 2.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.75B | 2.52B | 2.59B | 2.71B | 2.75B | 2.82B |
| Cash & ST investments | 305.30M | 320.10M | 400.00M | 521.70M | 401.00M | 441.60M |
| Inventory | 1.28B | 1.35B | 1.37B | 1.32B | 1.38B | 1.38B |
| Total assets | 14.03B | 13.90B | 13.87B | 13.92B | 13.78B | 13.75B |
| Total current liabilities | 1.22B | 1.26B | 1.27B | 1.26B | 1.26B | 1.24B |
| Short-term debt | 42.80M | 42.90M | 43.00M | 62.60M | 63.90M | 64.90M |
| Long-term debt | 5.29B | 4.85B | 4.78B | 4.76B | 4.68B | 4.59B |
| Total liabilities | 7,601,900,000.00 | 7,194,800,000.00 | 7,101,800,000.00 | 7,067,700,000.00 | 6,965,900,000.00 | 6,828,200,000.00 |
| Total equity | 6.43B | 6.71B | 6.77B | 6.85B | 6.81B | 6.92B |
| Retained earnings | 2.08B | 2.13B | 2.19B | 2.23B | 2.27B | 2.36B |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 362.70M | 408.50M | 435.40M | 357.70M | 436.20M | 715.30M | 609.40M | 990.80M |
| Depreciation & amortization | 142.40M | 134.50M | 131.40M | 170.60M | 307.40M | 492.80M | 511.80M | 500.60M |
| Free cash flow | 285.10M | 316.10M | 387.90M | 303.20M | 352.40M | 596.20M | 499.90M | 893.10M |
| Dividends paid | -47.20M | -48.90M | -48.70M | -335.60M | -90.90M | -92.80M | -93.00M | -93.00M |
| Stock buybacks / issuance | -127.80M | -165.10M | -25.00M | -25.80M | -239.20M | 0 | -50.00M | 0 |
| Ending cash balance | 248.60M | 331.40M | 611.30M | 672.80M | 688.50M | 635.30M | 393.50M | 521.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 102.30M | 523.20M | 197.50M | 167.80M | 14.90M | 176.70M |
| Depreciation & amortization | 125.50M | 122.30M | 129.20M | 123.60M | 123.90M | 124.90M |
| Free cash flow | 85.50M | 493.00M | 174.00M | 140.60M | -2.50M | 154.20M |
| Dividends paid | -23.20M | -23.40M | -23.10M | -23.30M | -23.30M | -23.30M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 305.30M | 320.10M | 400.00M | 521.70M | 401.00M | 441.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.97 | 10.25 | 7.73 | 4.74 | 7.70 | -0.90 | 3.11 | 4.27 |
| ROA %i | 5.13 | 5.28 | 4.20 | 2.82 | 4.76 | -0.45 | 1.33 | 2.00 |
| ROIC %i | 7.74 | 7.71 | 5.94 | 4.16 | 6.58 | 2.32 | 4.05 | 4.56 |
| 5-year avg ROE %i | 7.78 | 9.52 | 9.58 | 8.56 | 8.14 | 5.97 | 4.54 | 3.86 |
| EBIT margin %i | 9.53 | 11.02 | 9.99 | 9.05 | 13.43 | 6.87 | 10.73 | 11.82 |
| FCF / sales %i | 7.82 | 9.76 | 13.34 | 7.96 | 6.75 | 9.54 | 8.29 | 15.05 |
| Current ratioi | 2.66 | 2.87 | 2.25 | 2.56 | 2.99 | 2.55 | 2.26 | 2.15 |
| Quick ratioi | 1.17 | 1.41 | 1.27 | 1.33 | 1.48 | 1.13 | 1.02 | 0.83 |
| Debt / assetsi | 28.27 | 27.31 | 25.02 | 19.63 | 20.82 | 42.45 | 39.96 | 35.49 |
| LT debt / equityi | 56.55 | 50.53 | 35.19 | 31.45 | 32.53 | 102.60 | 88.93 | 71.28 |
| Interest coveragei | 6.29 | 6.73 | 7.30 | 5.71 | 8.04 | 1.00 | 1.62 | 2.01 |
| Revenue CAGR (3Y) %i | 1.27 | 0.14 | -4.72 | 1.48 | 17.24 | 29.07 | 16.56 | 4.38 |
| Net income CAGR (3Y) %i | 17.29 | 5.51 | -4.13 | -0.23 | 26.96 | -- | -5.11 | -17.00 |
| FCF CAGR (3Y) %i | -0.81 | -5.71 | 19.61 | 2.07 | 3.69 | 15.40 | 18.14 | 36.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.69 | 3.84 | 3.88 | 4.27 | 4.33 | 4.76 |
| ROA %i | 1.61 | 1.76 | 1.81 | 2.00 | 2.06 | 2.34 |
| ROIC %i | 4.32 | 4.58 | 4.53 | 4.56 | 4.60 | 4.91 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.42 | 11.31 | 11.26 | 11.82 | 11.60 | 12.05 |
| FCF / sales %i | 8.82 | 15.17 | 15.95 | 15.05 | 13.43 | 7.70 |
| Current ratioi | 2.26 | 2.00 | 2.05 | 2.15 | 2.17 | 2.28 |
| Quick ratioi | 0.95 | 0.69 | 0.72 | 0.83 | 0.77 | 0.82 |
| Debt / assetsi | 38.87 | 35.99 | 35.55 | 35.49 | 35.28 | 34.66 |
| LT debt / equityi | 84.26 | 74.05 | 72.28 | 71.28 | 70.50 | 67.99 |
| Interest coveragei | 1.75 | 1.80 | 1.85 | 2.01 | 2.05 | 2.20 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Industrial Powertrain Solutions is the largest reported line at 43.12% of revenue, across 4 reported segments.
- No single line clears half of revenue; Automation & Motion Control is next at 30.85%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Industrial Powertrain Solutions43.12%
Automation & Motion Control30.85%
Power Efficiency Solutions26.41%
Quote time 2026-10-08 08:28:40 · For reference only, not investment advice and not tailored to your situation.